June 2, 2026 | Eastern Time (US & Canada) | Online
Join leading parasitologists, clinicians, and researchers for a global virtual symposium dedicated to advancing research and collaboration in schistosomiasis.
Building on the outstanding success of our 2025 edition which showcased pioneering presentations on schistosomiasis treatment, immunopathology, and control strategies from leading experts at Tufts, Penn State, Stanford, and other distinguished institutions this year’s II Global Virtual Symposium on Schistosomiasis scheduled for 2026 aims to further strengthen dialogue and collaboration across the field.
Expanding on this momentum, the program will feature new insights into drug development, genomics, and emerging global health challenges.
Schistosomiasis remains a major global health challenge, causing significant morbidity and mortality worldwide. This symposium aims to foster collaboration, share cutting-edge research, and promote innovative solutions to improve public health outcomes.
This 1-day symposium will provide a valuable platform for basic, clinical, and translational research discussions. We look forward to welcoming you all on June 2, 2026 Online.
Baylor College of Medicine, TX
mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni
Penn State University, PA
NLRP3 and AIM2 inflammasomes exacerbate the pathogenic Th17 cell response to eggs of Schistosoma mansoni
PAI Life Sciences, WA
Interim clinical trial results for the Schistosomiasis vaccine, SchistoShield
University of York, UK
Using a human receptor platform to identify extracellular host: parasite protein interactions during Schistosoma mansoni infection
Charité Universitätsmedizin Berlin, Germany
Update of WHO ultrasound protocol for Schistosomiasis: "The Basel protocol"
Universidade Federal do Espírito Santo, Brazil
Updated concerns about accuracy studies of Schistosomiasis diagnostic methods
QIMR Berghofer Medical Research Institute, Australia
Next-generation molecular technologies for enhanced Schistosomiasis control
TUM School of Medicine and Health, Germany
Lipid metabolism as a vulnerability in schistosomes
Brown University Health, RI
Praziquantel for the treatment of pregnant women with Schistosomiasis: results of an RCT
Brown University, RI
Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT addressing optimal dosing and impact on morbidity
University of Texas Health Science Center at Houston, TX
Exploring the host and parasite factors modulating schistosome development and immune evasion
Stanford University School of Medicine, CA
Schistosomiasis fibrosis in focus: novel pathways and therapeutic opportunities
Hear groundbreaking studies from global experts.
Access recorded talks at your convenience.
Engage with professionals worldwide in live sessions.
Receive a certificate of participation and attend cost-effectively without travel expenses.
Price: $39 per person
Number of Tickets: 1
Processing payment...